Merck v. Integra: (section) 271(e) (1) and the common law research exemption.

This document cites

• Federal Cases - 21 F.Cas. 554 (C.C.D.Mass. 1813), 12,391, Sawin v. Guild
• Federal Cases - 29 F.Cas. 1120 (C.C.D.Mass. 1813), 17,600, Whittemore v. Cutter
• Federal Cases - 666 F.Supp. 1379 (N.D.Cal. 1987), C-83-5423, Scripps Clinic and Research Foundation v. Genentech, Inc.
• Federal Cases - 775 F.Supp. 1269 (N.D.Cal. 1991), No. C 90 20233, Intermedics, Inc. v. Ventritex, Inc.
• Federal Cases - 547 F.2d 1106 (Fed. Cir. 1976), 50328, Pitcairn v. United States



See all quotations

• Federal Cases - 733 F.2d 858 (Fed. Cir. 1984), 84-560, Roche Products, Inc. v. Bolar Pharmaceutical Co., Inc.
• Federal Cases - 307 F.3d 1351 (Fed. Cir. 2002), 01-1567, Madey v. Duke University
• Federal Cases - 331 F.3d 860 (Fed. Cir. 2003), 02-1052, Integra Lifesciences I, Ltd. v. Merck KGaA
• Federal Cases - 423 F.3d 1335 (Fed. Cir. 2005), 05-5012, Strickland v. United States
• Federal Cases - 489 U.S. 141 (1989), 87-1346, Bonito Boats, Inc. v. Thunder Craft Boats, Inc.
• Federal Cases - 496 U.S. 661 (1990), 89-243, Eli Lilly and Company v. Medtronic, Inc.
• Federal Cases - 545 U.S. 193 (2005), 03-1237, KGaA v. Integra Lifesciences I, Ltd.
• Federal Cases - 351 U.S. 292 (1956), 92, Black v. Cutter Laboratories